Positioning Imatinib for Pulmonary Arterial Hypertension (PIPAH) study

Back

ESC Professional Premium Access

Positioning Imatinib for Pulmonary Arterial Hypertension (PIPAH) study

Session: Current pharmacological treatments for pulmonary hypertension

Topic: Pharmacotherapy

Speaker: Professor A. Rothman (Sheffield, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Alexander Rothman

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

8 more presentations in this session

Effects of beta blockers on outcome in patients with PAH with and without comorbid conditions: a Multicenter Prospective Cohort Study (BNP-PL).

Speaker: Doctor M. Waligora (Krakow, PL)

Combined ARNI and SGLT2i impacts on peak tricuspid regurgitant velocity and echocardiographic probability of pulmonary hypertension

Speaker: Doctor M. Stracqualursi (Milan, IT)

The safety and efficacy of treprostinil for the treatment of pulmonary arterial hypertension: a systematic review and meta-analysis of randomized controlled trials

Speaker: Mr H. Khasawneh (Irbid, JO)

Efficacy and tolerability of triple sequential combination therapies with selexipag in patients with pulmonary arterial hypertension : insights from a single-centre study

Speaker: Doctor H. Tokgoz (Istanbul, TR)

Metoprolol therapy in patients with Eisenmenger syndrome (MINES) study. A single-centre, double-blinded, randomised, placebo-controlled trial

Speaker: Doctor A. Pius (New Delhi, IN)

Access the full session

Current pharmacological treatments for pulmonary hypertension

Speakers: Professor A. Rothman, Doctor M. Waligora, Doctor M. Stracqualursi, Mr H. Khasawneh, Doctor H. Tokgoz...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources